• Tactics of surgical treatment of hysteromyoma at women with disturbance of genesial function

Tactics of surgical treatment of hysteromyoma at women with disturbance of genesial function

HEALTH OF WOMAN. 2018.7(133):116–120; doi 10.15574/HW.2018.133.116

Litvak E. O. , Dovgan A. A.
Shupyk National Medical Academy of Postgraduate Education MH of Ukraine, Kiev

The objective: to increase efficiency of surgical treatment of hysteromyoma at women of genesial age on the basis of preoperative use medicamental correction.

Materials and methods. Сlinical-laboratory and functional examination of 130 women of genesial age was conducted, at 100 from which there was diagnostic hysteromyoma. 1 (main) group was made by 50 women with a hysteromyoma at whom in addition used as preoperative preparation a preparation which contains ulipristalacetat in a dosage of 5 mg per day within 12 weeks. 2 (comparisons) group made also 50 women with a hysteromyoma who received preoperative preparation gestagens. The control group was made by 30 women of similar genesial age without gynecologic pathology.

Results. Introduction in clinical practice of preoperative preparation by preparation ulipristalacetat with the subsequent combined operative measure (hystero-laparoscopy) in one stage with applying of endoscopic seams on a wall of a uterus promotes depression of an intraoperative hemorrhage; to decrease to the volume of infusional therapy and early restoration of fertility function of patients.

Conclusion. Use of the algorithm improved by us will allow to increase efficiency of treatment of sterility at women with hysteromyoma.

Key words: hysteromyoma, sterility, surgical treatment.

REFERENCES

1. Okoro Bonaventure. (2016). Sovremennyie podhodyi k vyiboru lechebnoy taktiki vedeniya bolnyih s miomoy matki. Mіzhnarodniy medichniy zhurnal 22;2:43-46.

2. Tatarchuk TF. (2016). Mioma matky: likuvannia z metoiu dovhostrokovoho kontroliu. Zhinochyi likar 1:3-7.

3. Tatarchuk TF. (2016). Organosohranyayuschee lechenie simptomnoy leyomiomyi matki u patsientok reproduktivnogo vozrasta. Reproduktivna endokrinologіya 2(28):94-99.

4. Tatarchuk TF. (2014). Novaya era v lechenii miomyi matki u zhenschin razlichnyih vozrastnyih grupp. Reproduktivna endokrinologіya 6(20):9-19.

5. Nakaz MOZ Ukrainy № 676 vid 31.12.2004 r. «Pro zatverdzhennia klinichnykh protokoliv z akusherskoi ta hinekolohichnoi dopomohy».

6. Nakaz MOZ Ukrainy № 905 vid 27.12.2006 r. «Pro zatverdzhennia klinichnykh protokoliv z akusherskoi ta hinekolohichnoi dopomohy».

7. Burlev VA. (2017). Lokalnyiy i sistemnyiy angiogenez u bolnyih s miomoy matki. Problemy reproduktsii 13;1:26-33.

8. Davyidov AI. (2016). Vozmozhnosti 3D transvaginalnoy ehografii v diagnostike dobrokachestvennyih zabolevaniy matki i pridatkov. Voprosyi ginekologii, akusherstva i perinatologii 1:47-52.

9. Kamenetskiy B. (2011). Dopplerometriya krovotoka v sosudah matki kak prognosticheskiy faktor pri lechenii besplodiya metodami vspomogatelnoy reproduktsii. Problemy reproduktsii 4:4-17.